Skip to main content

Table 2 Odevixibat treatment

From: Odevixibat therapy in progressive familial intrahepatic cholestasis with MYO5B variants: a retrospective case series

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Starting daily dose

120 µg/kg

67 µg/kg

37.2 µg/kg

40 µg/kg

37.5 µg/kg

Dose escalation

No

No

48 µg/kg

No

65 µg/kg

Dose at last follow-up

110.3 µg/kg.d) (4800 µg/d)

50 µg/kg.d (1200 µg/d)

40 µg/kg.d

(1200 µg/d)

46 µg/kg.d

(600 µg/d)

 

Duration of follow-up with treatment

39 months

39 months

22 months

22 months

34 months

Treatment interruption

Yes

No

No

Yes

No

Treatment rechallenge

Yes

No

No

Yes, at 20 µg/kg.day then full dose 40 µg/kg.day

No